|Bid||116.63 x 800|
|Ask||116.70 x 900|
|Day's Range||115.64 - 117.60|
|52 Week Range||74.75 - 139.55|
|Beta (5Y Monthly)||1.22|
|PE Ratio (TTM)||128.35|
|Earnings Date||Feb 07, 2024 - Feb 12, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||125.65|
Subscribe to Yahoo Finance Plus to view Fair Value for DXCM
Michael Brown, the Executive Vice President and Chief Legal Officer of DexCom Inc, has recently sold 3,612 shares of the company's stock.
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Inflation remained on a downward trend in the quarter and the fund’s Investor Class fund ARTMX returned -2.95%, Advisor Class fund APDMX posted a return of -2.92%, and Institutional Class […]
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.